Current role
Biotechnology · Healthcare
Chairman
2024-05-24–present
Robert Hershberg, M.D., Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Recursion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RXRX alertsAbout Robert Hershberg, M.D., Ph.D.
Robert Hershberg, M.D., Ph.D. is recorded as Chairman at Recursion Pharmaceuticals, Inc. (RXRX) since May 24, 2024. Recursion Pharmaceuticals, Inc. reported in an 8-K filed November 5, 2025 that Robert Hershberg, M.D., Ph.D. was appointed Vice Chair and Lead Independent Director, effective January 1, 2026. Recursion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Recursion Pharmaceuticals, Inc. includes Christopher C. Gibson (CEO and Board Member), Najat Khan (CEO), Najat Khan, Ph.D. (CEO and Board Member) and 7 others.
“On November 4, 2025, and in connection with the appointment of Dr. Gibson as Chair of the Board, the Board appointed Robert Hershberg, M.D., Ph.D. to serve as its Vice Chair and Lead Independent Director, effective as of January 1, 2026.”
Affiliation history
-
Current
2026-01-01–present
-
Current
2024-05-24–present
Company network
Leadership on record at Recursion Pharmaceuticals, Inc.
- Christopher C. Gibson CEO, Board Member
- Najat Khan CEO
- Najat Khan, Ph.D. CEO, Board Member
- Christopher Gibson, Ph.D. Chairman
- Ben Taylor CFO
- Kristen Rushton COO
- Tina Marriott COO
- David Hallett CTO, Board Member
- Blake Borgeson Board Member
- Dean Y. Li Board Member